Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

  • There is currently no data for NSCI

Board Changes

31 Mar 2020 07:00

RNS Number : 0751I
NetScientific PLC
31 March 2020
 

 

 

NetScientific plc

("NetScientific" or the "Company")

 

Board Changes

 

 

London, UK - 31 March 2020 - NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, today announces planned changes to its Board of Directors.

 

Sir Richard Sykes will retire from the Board following nine years as Chairman. John Clarkson, currently a Non-Executive Director of the Company, will take over as the Chairman of the Board with immediate effect.

 

In addition, Ian Postlethwaite will retire from the Board and step down as CEO/CFO and Company Secretary following four years at Netscientific during April 2020.

 

It is expected that Dr. Ilian Iliev, currently a Non-Executive Director, will become a part time Executive Director and interim CEO once terms have been agreed. A further announcement will be made at this point.

 

Finally, it is anticipated that Stephen Crowe, currently Financial Controller, will take over as interim CFO during April 2020 once terms have been agreed.

 

John Clarkson, Chairman of NetScientific, said: "We would like to thank Sir Richard and Ian for their significant contributions to the Company. Sir Richard has provided great strategic insight and direction during his time on the Board as Chairman and we wish him well in the future. The Board would also like to put on record its gratitude to Ian for his commitment and leadership of Netscientific since joining in 2016, during a very challenging period and wishes him every success in his future interests."

 

# # #

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Following the publication of this announcement, this inside information is now considered to be in the public domain.

 

For more information, please contact:

 

  NetScientific

Ian Postlethwaite, CEO/CFO

Tel: +44 (0)20 3514 1800

WHIreland (NOMAD, Financial Adviser and Broker)

Chris Fielding / Darshan Patel

Tel: +44 (0)20 7220 1666

MO PR ADVISORY (Press Contact)

Mo Noonan

Tel: +44 (0)78 7644 4977

 

 

About NetScientific

NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. 

 

For more information, please visit the website at www.NetScientific.net

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAJMMBTMTIJBFM
Date   Source Headline
29th Jul 20144:23 pmRNSNetScientific announces shareholder name change
23rd Jul 20148:27 amRNSNetScientific Invests in Breakout Labs Companies
21st Jul 201411:43 amRNSTR1 - Notification of Major Interest in Shares
11th Jul 201411:50 amRNSTR1 - Notification of Major Interest in Shares
4th Jul 20142:11 pmRNSNotification of Major Interest In Shares
2nd Jul 20147:00 amRNSResearch Programme in DNA Sequencing
9th Jun 20144:34 pmRNSNetScientific plc
20th May 20145:33 pmRNSResult of AGM
20th May 20147:00 amRNSAGM Statement
19th May 20147:00 amRNSAnnouncement of research agreement with Harvard
8th May 201410:18 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20147:00 amRNSNetScientific Partners with Breakout Labs
19th Mar 20147:00 amRNSPreliminary results
13th Mar 20144:07 pmRNSNotice of Results
24th Feb 20147:00 amRNSNetScientific invests in ProAxsis
30th Sep 20137:00 amRNSDirector Dealings
27th Sep 20137:00 amRNSInterim results for six months ended 30 June 2013
16th Sep 20137:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.